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EDITORIAL OF THE ISEV BOARD
Updating the MISEV minimal requirements for extracellular vesicle studies:
building bridges to reproducibility
An editorial describing “minimal experimental require-
ments for definition of extracellular vesicles (EVs)”, or
more simply “minimal information for studies of EVs
(MISEV)” was published in the Journal of Extracellular
Vesicles in late 2014 [1]. Similar to guidelines in other
scientific fields [2–4], “MISEV2014”, as we will call it
here, provided recommendations on experimental
methods and minimal information in reporting.
Specifically, three key areas were addressed: EV isola-
tion/purification, EV characterization and EV func-
tional studies (see Text Box 1).
Brief review of MISEV2014
On separation of EVs (also referred to as isolation,
purification or concentration), MISEV2014 acknowl-
edged that there is no consensus on an “optimal”
method, such as ultracentrifugation, size exclusion or
immunoaffinity. Instead, selection of a method should
be guided by the relevant scientific question and down-
stream applications, and all details of the method
should be provided to ensure reproducibility.
MISEV2014 recommended that EVcharacterization be
performed at both the population and single vesicle levels.
For the former, both positive and negative protein marker
characterization was endorsed, following four categories of
proteins: (1) transmembrane or lipid-bound EV protein,
(2) EV cytosolic protein, (3) intracellular but not associated
with plasma membrane or endosomes (i.e. relatively less
abundant in exosomal EVs than in cells) and (4) extra-
cellular but not typically EV-associated proteins. Several
examples of proteins in each category were provided.
For characterization of single vesicles, as a means to
assess population heterogeneity, MISEV2014 called for
the use of at least two different but complementary
technologies. For example, electron or atomic force
microscopy could be paired with one of the single
particle tracking methods. Furthermore, close-up
images should be accompanied by wide-field views to
allow assessment of heterogeneity.
For EV functional studies, MISEV2014 stated that quan-
titation of EVs and their activity should include dose–
response studies. Process controls should be included,
since contaminants might contribute activity. Use of
density gradients was encouraged to show that any
observed activity is intrinsic to EVs and not to closely
associated, commonly co-purifying particles; alternatively,
this activity should be depletable, e.g. by immunodepletion
of EVs. Labelling studies were also recommended.
Rigour vs flexibility
MISEV2014 reflected a field in flux, with a need for stan-
dard development tempered by remaining uncertainties.
Indeed, this is still the case. For this reason, the protein
markers for general characterization that were listed in a
table in the manuscript were presented as non-exclusive
examples only, and no specific antibodies were recom-
mended. Our understanding of categories such as “EV
proteins” and “non-EV proteins” is still evolving, and
these categories might better be labelled “EV-enriched”
and “EV-depleted”. Some described non-EV proteins
have been found in vesicles and have biological effects.
Instead of an inflexible approach, MISEV2014 urged that
markers from different categories be used, and that all
antibody details and sample manipulations be reported to
ensure interpretability and reproducibility. What if scien-
tists could not follow all guidelines? In this case, they were
encouraged to explain why certain experiments could not
be performed. The example of low-abundance, precious
samples was given explicitly. That is, guidance was accom-
panied by acknowledgement of the realities of the field.
Utility of MISEV2014
The value of MISEV2014 is supported by a key finding of
van Deun and Hendrix [5] reporting on the release of the
EV-TRACK knowledgebase [6]. The EV-TRACK project
includes an “EV-METRIC” that can be calculated to gauge
the quality of reporting of each EV-related paper. van
Deun et al. found that, in the year after the release of
MISEV2014, the EV-METRICs of publications overall
did not improve significantly. However, publications that
cited MISEV2014 had significantly higher EV-METRICs.
Those who engaged withMISEV2014, then, seemed to be
better equipped to report important experimental para-
meters. Of course, it takes time for laboratories to incor-
porate new methodologies and then go on to publish a
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paper based on them. Laboratories that were unaware of
the MISEV effort before its publication may simply not
have had time to incorporate the guidelines by the time
our survey took place. How far has MISEV reached?
Citations of MISEV2014 reached 400 in September
2017, according to Google Scholar. However, this num-
ber represents only aminority of EV-related publications.
While MISEV is likely followed in many publications that
do not cite it, and citations per se are certainly not the
goal of standardization efforts, the MISEV2014 citation
rate nonetheless suggests that broader dissemination and
researcher involvement could be achieved.
Opportunities and pulse-checking
The ISEV community now faces choices to extend the
value and reach of MISEV2014. Whereas MISEV2014
was produced by the ISEVBoard ofDirectors as the elected
representatives of ISEV – at that time including the three
editors-in-chief of the Journal of Extracellular Vesicles –
future developments will benefit from the input of a much
broader authorship. Drawing on more expertise will allow
a future iteration or offshoot of MISEV2014 to offer more
detailed guidance in more areas, and/or to reflect greater
consensus. A first step in this directionwas to take the pulse
of the community on where we came from (MISEV2014)
and where we are going with standardization.
2016 MISEV survey: obtaining guidance from
the experts
A 14-question MISEV survey was released to the ISEV
membership on 24 October 2016. See Text Box 2 for an
outline of the survey. A total of 187 responses were sub-
mitted: 81% (152) within a 24-hour period, and almost
95% within 5 days. The survey was closed in early 2017.
Respondents and their engagement with the
MISEV2014 guidelines (Questions 1–3)
Eighty-two per cent of respondents had read the
MISEV2014 guidelines, whereas 18% had not. Fifty-six
per cent of all respondents had published on EVs in 2015
or 2016 (i.e. afterMISEV2014 appeared), whereas 44% had
not. A slightly larger percentage of recent authors had read
MISEV2014 (87%) compared with those who had not
published on EVs recently (74%, Figure 1(a)). Seventy-
one per cent of recently publishing authors indicated that
they followed and/or cited MISEV2014 in their work
(Figure 1(b)).
Perceived importance of guidelines (Questions 4
and 5)
Since the MISEV2014 authors have received a wide range
of praise and critical comments on the guidelines, we
sought to determine how the ISEV community viewed
EV reporting or experimental guidelines in general and
MISEV2014 specifically. When the question was phrased,
“Do you think that minimal reporting and/or methodo-
logic requirements are important for the EV field?”
(Question 4), only one respondent answered “no”
(Figure 2(a)). There was thus near-unanimity among
respondents that requirements are needed.
A diversity of underlying opinions became apparent,
though, through Question 5, a multiple-choice question
about MISEV2014 in particular. Almost all respondents
saw requirements as “important”, and a majority (53%)
supported MISEV2014 as is. However, 25% considered
MISEV2014 to be too restrictive, whereas 16% said it was
not stringent enough (Figure 2(b)). Four per cent thought
that MISEV2014 was an unnecessary imposition on the
field. In conclusion, most survey participants are in favour
of standards, with a majority of respondents supporting
MISEV2014. It is clear, though, that sizeable portions of the
ISEV constituency might favour updates and changes to
MISEV2014.
Text Box 1. Major recommendations of MISEV2014.
1. EV separation/isolation
a) There is no single optimal isolation method, so choose based
on the downstream applications and scientific question
b) Report all details of the method(s) for reproducibility
2. EV characterization
a) General characterization. Show:




ii. At least one negative protein marker
b) Characterization of single vesicles: use two different but
complementary techniques, for example:
i. electron or atomic force microscopy (and show both close-
up and wide-field)
ii. single particle tracking
3. Functional studies should include:
a) Dose–response studies
b) Process controls to rule out influence of serum components/
other possible contaminants
c-i.) Density gradients to show activity is intrinsic to EVs, not just
associated
or c-ii.) EV depletion to remove activity
or c-iii.) EV/cell labelling (e.g., fluorescent labelling, with careful
interpretation)
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Who should update MISEV2014 (Questions 6 and 7)?
As for ISEV’s role in updates to MISEV2014, approxi-
mately 80% of respondents named ISEV, “with its large
and diverse membership”, as the ideal body to issue
requirements (Figure 3(a)). Other responses included “no
preference” and nods to local or regional societies. Around
10% of respondents suggested that individual laboratories
or scientists should publish requirements and that those
with the highest impact factors or citations would become
Text Box 2. ISEV 2016 MISEV survey.
1. I have read the MISEV minimal requirements paper (Lötvall et al., JEV, 2014) (yes/no)
2. I have published on extracellular vesicles in 2015 and/or 2016 (yes/no)
3. In your recent EV publication(s), did you (follow/cite/not follow or cite) MISEV?
4. Do you think that minimal reporting and/or methodologic requirements are important for the EV field? (yes/no)
5. Which of the following most closely summarizes your opinion on minimal requirements in the EV field?
° Minimal requirements are important, and I support MISEV
° Minimal requirements are important, and MISEV does not go far enough to uphold standards
° Minimal requirements are important, but MISEV is too restrictive
° Minimal requirements such as MISEV are an unnecessary imposition on the EV field
° I don’t have strong feelings about minimal requirements6. If standards are to be adopted, which of the following is preferable?
° ISEV, with a large and diverse membership, should continue to take the lead in establishing minimal requirements
° Minimal requirements are better established by national societies or regional collaborative networks
° Leading experts or laboratories should develop and publish their own standards, and the best (highest IF or most cited) publications willeventually become the de facto standards in the field
° I have no preference7. An update to MISEV is planned . . . how should it proceed?
° The ISEV board and JEV editors should update MISEV as they see fit.
° The ISEV board should also recruit ISEV members who are not on the board to assist in updating MISEV
° The ISEV community as a whole should be involved in updating MISEV, with invitations to contribute to specific points; community-widevoting is not needed
° The ISEV community should be involved not only in contributing/feedback, but also in voting to ratify specific points8. Please comment on sections/types of information should be retained in future MISEV updates (check all that are applicable)
° minimal requirements to claim the presence of EVs in isolates
° general characterization of EVs
° characterization of single EVs
° studies of functional activities of EVs
° recommendations for controls
° other/comments on the above9. Needed additions to MISEV include:
° Advice on pros and cons of different isolation methods
° Advice on protein markers to use for different types of EVs
° Advice on reliable antibodies for the EV protein markers, for different applications (WB, flow cytometry, immunohistochemistry, EM, etc.)
° Other (please specify)10. If you would like to be involved in drafting or reviewing an update to MISEV, please provide your email address. Note: There will be additional
opportunities to join the effort if you prefer not to disclose here. (Free form, optional)
11. If you would like to be involved in drafting or reviewing an update to MISEV, please describe your expertise in the EV field (e.g., published
articles, unpublished work, specific areas of interest) (short answer, optional)
12. The following ISEV members should be consulted on MISEV updates (free form, optional)
13. If required, I/my laboratory are likely willing and able to devote a reasonable amount of resources to evaluate specific methods/reagents in
the laboratory as needed to support a new MISEV release or other field-wide evaluation (yes/no)
14. Please share any other comments you may have (free form, optional)
Figure 1. Community engagement with MISEV.
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the de facto standards. The overwhelming emphasis on
ISEV, however, places a responsibility on the society –
leadership and membership – to advance standardization
efforts for the field.
One unambiguous outcome of the survey was that ISEV
board members and JEV editors are not encouraged to
update MISEV2014 alone. This approach was endorsed by
only 4% of respondents (Figure 3(b)). Thirty-five per cent
of participants asked the ISEV board to include ISEV
members who are not on the board, and 62% felt that the
entire ISEV community should be invited to participate.
Of the latter group, approximately three in four said that
community voting would not be necessary, whereas one in
four favoured community-wide voting on specific points.
Assembling a team for ongoingstandardization
efforts
A key goal of the MISEV2014 survey was to begin the
process of identifying EV experts in addition to the pre-
vious MISEV2014 authorship and the ISEV Board of
Directors who are able and willing to contribute to future
community efforts. Sixty-eight respondents volunteered by
providing their email addresses. Only two of these respon-
dents were MISEV2014 authors or members of the ISEV
Board of Directors. Fifty-six of the volunteers gave details
of their areas of expertise, including publications in many
cases. Additionally, 20 respondents suggested other EV
experts who, in their view, should be involved in future
updates toMISEV. These names included 22 whowere not
authors of the previous MISEV2014 publication and are
not on the current ISEV board. Only minimal overlap
between the “volunteers” and “volunteered” was observed.
Thus, in total, approximately 85 unique individuals were
identified as possible contributors. As stated in the survey,
additional calls for volunteers will be made in the future.
What topics should be retained or added
(Questions 8 and 9)?
The majority of respondents were in favour of keeping
all current components of MISEV2014, with 85% or
more supporting retention of minimal requirements to
claim presence of EVs in isolates, general characteriza-
tion of EVs and suggestions for controls. Smaller majo-
rities endorsed retention of single EV guidelines and
recommendations for functional studies (Figure 4(a)).
What should or could be added in future MISEV
updates? For Question 9, three choices were provided
(specific recommendations on isolation methods, specific
antibodies for detection andmarkers ofmultiple subtypes),
along with an “other” comments box. While the way in
which the survey was constructed prevented selection of
more than one choice, the responses including the free-
form comments made it clear that all selections were pop-
ular (Figure 4(b)). Updated recommendations on isolation
methods were requested, including assessment of the pro-
liferating commercial kit-based options to isolate EVs.
Recommendations for judging the purity of vesicles were
emphasized: while the presence of EVs is often shown, the
presence and percentage of contaminants continue to be
often ignored. Respondents suggested that contaminants
could be categorized further based on EV sources
(biofluids, tissues, cell-culture conditioned medium).
Some felt that lists of reliable antibodies to detect EV
positive or negative protein markers would be helpful, as
well as guidelines on RNA, lipids and other EV
Figure 2. Opinions about minimal requirements in the EV field.
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components. Further guidelines on isolation method for
functional studies were also raised, since isolationmethods
with different resultant purities may alter the functional
roles of EV in vivo. Issuing from this problem, recommen-
dations on experimental measurement of the activity of
impurities were deemed important to place the functional
roles of EVs in proper context.
Positive and negative markers and contamination
Examining the free-form comments for Questions 8 and 9,
multiple responses addressed the problem of contamina-
tion and positive and negative markers. How does one
recognize and quantitate the various possible contami-
nants? Can we arrive at a consensus purity measurement?
How can activity of non-EV components be excluded in
functional studies? What is a negative marker? Is it found
exclusively in non-EV contaminants, or can it also be
present, if at reduced relative amounts, in EVs? Should
positive EV markers merely be found in EVs, or must
they also be enriched?
Other suggestions for additions
Several commenters stressed the need to accommodate
studies of EVs from rare cell types, low-abundance body
fluids and other exceptions, and not simply take a “one-
size-fits-all” approach. Recommendations on different sub-
types of EVs were an item of interest for several
Figure 3. Who should establish and update minimal requirements?
Figure 4. MISEV: suggested retentions and additions.
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respondents, as were newer or newly applied methods for
EV separation. Other comments suggested topics such as
storage of EVs, assessment of stability and omics analysis
specific to EVs.
Final comments box
A final comments box in the survey was used by <7% of
respondents. Most of these free-form responses were posi-
tive general comments on MISEV. One comment sug-
gested that, for a MISEV update, a comprehensive review
of methodologies might be useful. Several commenters
emphasized that any futureMISEV release should continue
to allow for exceptions: cases where the requirements
might be waived or recognized as inapplicable. Further
action from the community to spread the word about EV
minimal standards to journals and journal editors was also
encouraged.
Where do we go from here? Building bridges to
enhance reproducibility in research
Revealing and centralizing methodologic details are part
of successful standardization. To this end, we recognize
with enthusiasm the EV-TRACK knowledgebase that was
announced in Nature Methods [6] and in the accompany-
ing letter to the editor [5]. We strongly encourage EV
researchers to join the EV-TRACK initiative (www.
evtrack.org), to use its tools to help guide effective research
design and evaluation, and to obtain an EV-METRIC for
each manuscript. We also hope the EV-METRIC will be
included in submissions to the Journal of Extracellular
Vesicles and to other journals, as well.
How will MISEV be updated?
In addition to exciting initiatives like EV-TRACK,minimal
requirements in the field must also be updated regularly.
This will be a large task as the field grows, and input is
sought from a wider swath. We were interested to read a
“guidelines to guidelines” recently published by Daniel J.
Klionsky [7], noted autophagy researcher and the driving
force behind the well-known autophagy guidelines. These
guidelines, published in 2008 [8] and updated in 2012 [9]
and 2016 [10], now include several thousand authors who
reviewed the text and offered changes in a carefully guided
manner. Klionsky’s staged writing process and a distribu-
ted author invitation plan ensure efficient progress but
broad embrace of the global research body. In our view,
the type of community consensus and buy-in fostered by
this approach is exactly what we feel would be most valu-
able to EV researchers in an upcomingmanifestation of the
MISEV guidelines and also consistent with what the
MISEV survey respondents indicated about their willing-
ness and desire to be involved.
Regarding uncertainty
Standardization through MISEV updates is important, but
of course uncertainty will remain that cannot be removed
through minimal requirements alone. On many specific
questions in EV research, including, for example, some
quite basic matters of pre-analytical variables, the jury is
still out. Careful comparisons to resolve these questions are
conducted and published less often than might be optimal.
This is because of the resources they require, resources that
could otherwise be channelled into evaluating biological
hypotheses that are more likely to secure funding.
Importantly – and perhaps surprisingly to those who are
less familiar with our highly collaborative field – 55% of
respondents to the MISEV survey said that they or their
laboratories could “devote reasonable resources” to evalua-
tions, if these were to become necessary for MISEV
updates. The language was kept intentionally vague, but
“evaluations” could mean anything from literature reviews
to technical/experimental comparisons. It is encouraging
that such a large percentage of participants indicated a
willingness to engage in coordinated activities. As needed,
a Standardization Committee of ISEV could be formed to
establish working groups on topics that have not been fully
addressed and thus focus the substantial energies of the
community.
Summary
Overall, the response to the ISEV survey on MISEV2014
produced three core findings: the value of MISEV2014, the
need for regular updates that involve the wider community
and the strong commitment of the ISEV community to
advance the field through standardization efforts.
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